Skip to content
Research Triangle Regional Partnership
  • Our Region
    • The Triangle
    • Our Counties
    • Talent
    • International
  • Do Business Here
    • Incentives & Grants
    • Investment
    • Startup Ecosystem
    • Featured Sites
  • Target Industries
    • Advanced Manufacturing
    • AgTech
    • CleanTech
      • EV & Battery Tech
    • Life Sciences
      • Gene & Cell Therapy
      • Bioeconomy
    • Technology
      • Cybersecurity
      • Defense Technology
      • Fintech
  • Newsroom
  • About Us
  • Events
  • Contact
  • Select Language
    • en_USEnglish
    • es_ESEspañol
    • fr_FRFrançais
    • de_DEDeutsch
    • it_ITItaliano
    • pl_PLPolski
    • sv_SESvenska
    • fiSuomi
    • da_DKDansk
    • he_ILעִבְרִית
    • zh_CNChinese
    • zh_TW繁體中文
    • ko_KR한국어
    • ja日本語

Life Sciences

Study: Thousands of biopharma jobs coming to NC by 2024; average wage $97,575

Date Published: February 18, 2020
RESEARCH TRIANGLE PARK – North Carolina is widely known for its job-ready biopharma manufacturing workforce. And the newly published 2020…

Biotech startup Arrevus receives FDA orphan drug designation for cystic fibrosis treatment

Date Published: February 18, 2020
RALEIGH — Biotech startup Arrevus is one step closer to potentially extending the lifespans of those living with cystic fibrosis…

The Triangle’s big slice of NC bio/pharma pie – List Insights

Date Published: February 18, 2020
The life sciences industry is no doubt big business in North Carolina with more than 735 bioscience companies and a…

Duke spinout Polarean exceeds expectations with lung-imaging trial, seeks meeting with FDA

Date Published: February 7, 2020
A successful Phase 3 trial of Polarean Imaging’s drug-device combination for lung imaging has the Research Triangle Park company poised…

NC State, biopharma company developing gene therapy for asthma

Date Published: February 6, 2020
NEW YORK, N.Y. —  Biopharmaceutical company Hoth Therapeutics has tapped NC State to collaborate and carry out a preclinical study…
North Carolina Biotechnology Center name on a brick sign.

NC Biotech CEO Doug Edgeton: ‘We will lead science behind curative gene, cell therapies”

Date Published: January 31, 2020
RESEARCH TRIANGLE PARK — For the better part of four decades, North Carolina has steadily committed resources to developing biotechnologies…

bluebird bio launches gene therapy for severe blood disorder in Germany

Date Published: January 29, 2020
DURHAM — bluebird bio, a gene therapy company with operations in Durham, has launched for the first time its treatment…

A world first: Triangle’s Locus Biosciences to launch gene editing trial involving therapy ‘cocktail’

Date Published: January 10, 2020
Morrisville-based Locus Biosciences, a developer of precision antibacterial therapies, will conduct the world’s first clinical trial of a recombinant bacteriophage…

Duke researchers land $6M in federal grants to advance gene editing

Date Published: January 3, 2020
Hemophilia. Cystic fibrosis. Duchenne muscular dystrophy. Huntington’s disease. These are just a few of the thousands of disorders caused by…

Contact Us

Send us an email to learn more about the Research Triangle Region.

Ryan Combs Executive Director, Research Triangle Regional Partnership Email rcombs@researchtriangle.org Email Research Triangle, North Carolina
A Special Thank You To Our Corporate Partners
Delta
Official Airline of the RTRP
Duke Energy
©2025 Research Triangle Regional Partnership
  • LinkedIn
  • YouTube
  • Accessibility
  • Privacy Policy
  • Sitemap